Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 24

1.

New strategies for stem cell mobilization.

Lemoli RM.

Mediterr J Hematol Infect Dis. 2012;4(1):e2012066. doi: 10.4084/MJHID.2012.066. Epub 2012 Oct 3.

2.

Preemptive use of plerixafor in difficult-to-mobilize patients: an emerging concept.

Jantunen E, Lemoli RM.

Transfusion. 2012 Apr;52(4):906-14. doi: 10.1111/j.1537-2995.2011.03349.x. Epub 2011 Oct 7. Review.

PMID:
21981351
3.

Plerixafor: a review of its use in stem-cell mobilization in patients with lymphoma or multiple myeloma.

Keating GM.

Drugs. 2011 Aug 20;71(12):1623-47. doi: 10.2165/11206040-000000000-00000. Review.

PMID:
21861545
4.

Plerixafor: a peripheral blood stem cell mobilizer.

Kessans MR, Gatesman ML, Kockler DR.

Pharmacotherapy. 2010 May;30(5):485-92. doi: 10.1592/phco.30.5.485. Review.

PMID:
20411999
5.

Management strategies for poor peripheral blood stem cell mobilization.

Moog R.

Transfus Apher Sci. 2008 Jun;38(3):229-36. doi: 10.1016/j.transci.2008.04.002. Epub 2008 May 15. Review.

PMID:
18485822
6.

Novel strategies for blood stem cell mobilization: special focus on plerixafor.

Jantunen E.

Expert Opin Biol Ther. 2011 Sep;11(9):1241-8. doi: 10.1517/14712598.2011.601737. Review.

PMID:
21806478
7.

How I treat patients who mobilize hematopoietic stem cells poorly.

To LB, Levesque JP, Herbert KE.

Blood. 2011 Oct 27;118(17):4530-40. doi: 10.1182/blood-2011-06-318220. Epub 2011 Aug 10. Review.

8.

Plerixafor, a CXCR4 antagonist for the mobilization of hematopoietic stem cells.

Uy GL, Rettig MP, Cashen AF.

Expert Opin Biol Ther. 2008 Nov;8(11):1797-804. doi: 10.1517/14712598.8.11.1797 . Review.

PMID:
18847313
9.

In and out of the niche: perspectives in mobilization of hematopoietic stem cells.

Mohty M, Ho AD.

Exp Hematol. 2011 Jul;39(7):723-9. doi: 10.1016/j.exphem.2011.05.004. Epub 2011 May 13. Review.

PMID:
21624427
10.

Plerixafor for stem cell mobilization in patients with non-Hodgkin's lymphoma and multiple myeloma.

Choi HY, Yong CS, Yoo BK.

Ann Pharmacother. 2010 Jan;44(1):117-26. doi: 10.1345/aph.1M380. Epub 2009 Dec 15. Review.

PMID:
20009003
11.

Plerixafor hydrochloride: a novel agent for the mobilization of peripheral blood stem cells.

Cashen AF.

Drugs Today (Barc). 2009 Jul;45(7):497-505. doi: 10.1358/dot.2009.45.7.1395292. Review.

PMID:
19834627
12.

Physiology and pharmacology of plerixafor.

Fricker SP.

Transfus Med Hemother. 2013 Aug;40(4):237-45. doi: 10.1159/000354132. Epub 2013 Jul 19. Review.

13.

Update on clinical experience with AMD3100, an SDF-1/CXCL12-CXCR4 inhibitor, in mobilization of hematopoietic stem and progenitor cells.

Pusic I, DiPersio JF.

Curr Opin Hematol. 2010 Jul;17(4):319-26. doi: 10.1097/MOH.0b013e328338b7d5. Review.

PMID:
20473162
14.

Plerixafor: in patients with non-Hodgkin's lymphoma or multiple myeloma.

Wagstaff AJ.

Drugs. 2009;69(3):319-26. doi: 10.2165/00003495-200969030-00007. Review.

PMID:
19275275
15.
16.

Mobilization of hematopoietic stem cells into the peripheral blood.

Damon LE, Damon LE.

Expert Rev Hematol. 2009 Dec;2(6):717-33. doi: 10.1586/ehm.09.54. Review.

PMID:
21082960
17.

Mobilization strategies in hard-to-mobilize patients with lymphoid malignancies.

Jantunen E, Kvalheim G.

Eur J Haematol. 2010 Dec;85(6):463-71. doi: 10.1111/j.1600-0609.2010.01520.x. Review.

PMID:
20738393
18.

Systematic review of randomized controlled trials of hematopoietic stem cell mobilization strategies for autologous transplantation for hematologic malignancies.

Sheppard D, Bredeson C, Allan D, Tay J.

Biol Blood Marrow Transplant. 2012 Aug;18(8):1191-203. doi: 10.1016/j.bbmt.2012.01.008. Epub 2012 Jan 16. Review.

19.

Peripheral blood stem cell mobilization tactics.

Rosenbeck LL, Srivastava S, Kiel PJ.

Ann Pharmacother. 2010 Jan;44(1):107-16. doi: 10.1345/aph.1M289. Epub 2009 Dec 8. Review.

PMID:
19996324
20.

Advances in mobilization for the optimization of autologous stem cell transplantation.

Vose JM, Ho AD, Coiffier B, Corradini P, Khouri I, Sureda A, Van Besien K, Dipersio J.

Leuk Lymphoma. 2009 Sep;50(9):1412-21. doi: 10.1080/10428190903096701. Review.

PMID:
19603345
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk